期刊文献+

线粒体促凋亡因子Omi/HtrA2在膀胱移行细胞癌中的表达及临床意义 被引量:1

The expression and clinical significance of Omi/HtrA2 in the Bladder transitional cell carcinoma
下载PDF
导出
摘要 目的:探讨线粒体促凋亡因子Omi/HtrA2在膀胱癌组织、癌旁组织、膀胱正常粘膜组织中的表达及其临床意义。方法:应用流式细胞术方法检测44例膀胱癌组织,44例癌旁组织及12例膀胱正常粘膜组织Omi/HtrA2的表达。结果:1Omi/HtrA2的阳性表达率为膀胱癌组织81.9%(36/44),癌旁组织31.9%(14/44),正常膀胱粘膜25.0%(3/12);2Omi/HtrA2在膀胱移行细胞癌的阳性表达率情况为G1级83.3%(10/12),G2级65.2%(15/23),G3级22.2%(2/9);3Omi/HtrA2的表达与性别、年龄和临床分期无明显的关系。结论:1Omi/HtrA2在膀胱移行细胞癌组织中的阳性表达率明显高于正常粘膜组织和癌旁组织。2Omi/HtrA2蛋白在膀胱移行细胞癌组织中的表达水平与患者的年龄、性别以及肿瘤的分期无关,与膀胱癌病理分级有关。 Objective:Investigate the expression of Omi/HtrA 2 in the Bladder transitional cell carcinoma(BTTC) and peritumoral tissue and bladder normal mucosa and its significance in clinical medicine . Methods: The Traces of Omi/HtrA2 were detected by FCM in 44 samples of BTCC and 44 samples of peritumoral tissue and 12 samples of normal bladder mucosa . Results:①The positive expression rate of Omi/HtrA2 protein in BTCC was 81.9% (36/44), The positive expression rate in the peritumoral tissue was 31.9% (14/44), The positive expression rate in normal bladder mucosa was 25.0% (3/12).②The positive expression rate of Omi/HtrA2 protein in BTCC G1 grade was 83.3%(10/12), G2 65.2%(15/23), G3 22.2%(2/9).③The expression of Omi/HtrA2 and Surviving was no relationship with age, gender, clinical Stage. Conclusions:① The positive traces rate of Omi/HtrA2 protein in BTCC was higher than it in peritumoral tissue and the normal bladder mucosa.②The expression of Omi/HTRA2 was no relationship with age, gender, clinical Stage, but with pathological grading.
出处 《陕西医学杂志》 CAS 2010年第4期401-403,共3页 Shaanxi Medical Journal
关键词 膀胱肿瘤/免疫学 丝氨酸内肽酶类/免疫学 细胞凋亡 基因表达 Bladder neoplasms/immunology Serine endopeptidases/immunology Apoptosis Gene expression
  • 相关文献

参考文献2

二级参考文献26

  • 1Miyake H,Nelson C,Rennie P,et al.Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene Testosterone-repressed Prostate Message-2 in prostate cancer xenograft models[J].Cancer Res,2000,60(9):2547-2554. 被引量:1
  • 2Kevin R,McEleny R,William G,et al.Inhibitors of Apoptosis Proteins in Prostate Cancer Cell Lines[J].Prostate,2002,51 (2):133-140. 被引量:1
  • 3Whitehurst A W,Robinson F L,Moore M S,et al.The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions[J].J Biol Chem,2004,279(13):12840-12847. 被引量:1
  • 4Hao C,Beguinot F,Condorelli G,et al.Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells[J].Cancer Res,2001,61 (8):1162-1170. 被引量:1
  • 5Verhagen A M,Silke J,Ekert P G,et al.HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins[J].J Biol Chem,2002,277 (1):445 -454. 被引量:1
  • 6Lee S H,Lee J W,Kim H S,et al.Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer[J].APMIS,2003,111 (5):586-590. 被引量:1
  • 7Suzuki Y,Takahashi-Niki K,Akagi T,et al.Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways[J].Cell Death Differ,2004,11 (2):208-216. 被引量:1
  • 8Hegde R,Srinivasula S M,Zhang Z,et al.Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction[J].J Biol Chem,2002,277 (1):432-438. 被引量:1
  • 9Martins L M,Iaccarino I,Tenev T,et al.The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif[J].J Biol Chem,2002,277 (1):439-444. 被引量:1
  • 10Cilenti L,Kyriazis G A,Soundarapandian M M,et al.Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells[J].Am J Physiol Renal Physiol,2005,288(2):F371-F379. 被引量:1

共引文献12

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部